Home

Silver Point Capital, 10% Owner: Keenova Therapeutics Buy · Filed 25/12/10

Trade details

Type
Insider buy
Amount
$11,623,942.5
Shares · price
130,974 sh · $88.75 a share
Held after
4,702,714 sh
Stock
Keenova Therapeutics
Trade date
25/12/08
Filed
25/12/10
Days to filing
2 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+2.9%

Keenova Therapeutics trades, last 26 weeks

Silver Point Capital's recent trades

  • Silver Point Capital

    Planned saleQVC Group

    $11.8M

    Filed 09/03

  • Silver Point Capital

    Planned saleQVC Group

    $875K

    Filed 08/11

  • Silver Point Capital

    BuyKeenova Therapeutics

    $19M

    Filed 05/21

  • Silver Point Capital

    BuyKeenova Therapeutics

    $17M

    Filed 05/21

  • Silver Point Capital

    BuyKeenova Therapeutics

    $37.1M

    Filed 04/17

Silver Point Capital, 10% Owner — bought $11.6M of Keenova Therapeutics · 130,974 sh @ $88.75 | Whalegun